
Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
Author(s) -
Shripad Brahmanand Pande,
DC Doval,
Keechilat Pavithran,
JB Sharma,
Рашми Ширали,
Amarnath Jena
Publication year - 2012
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/0971-5851.96968
Subject(s) - gemcitabine , medicine , neutropenia , cisplatin , oncology , chemotherapy , gastroenterology , nausea , hepatocellular carcinoma
Gemcitabine, an anti-metabolite, has some activity in hepatocellular carcinoma (HCC) in terms of responses and median survival.